How should asymptomatic choledocholithiasis with normal liver function tests and no right‑upper‑quadrant pain be managed?

Management of Asymptomatic Choledocholithiasis with Normal LFTs

Active stone extraction through ERCP or laparoscopic bile duct exploration should be offered even to asymptomatic patients with confirmed common bile duct stones, because untreated stones lead to unfavorable outcomes including cholangitis, pancreatitis, and hepatic dysfunction. 1

Primary Management Recommendation

The British Society of Gastroenterology strongly recommends active stone removal over conservative management for all patients with confirmed common bile duct stones, not just symptomatic ones. 1 This recommendation prioritizes prevention of serious morbidity from complications that develop when stones are left in place—specifically pain, jaundice, infection, and acute pancreatitis. 1

The absence of symptoms and normal liver function tests does not change the fundamental management approach: confirmed choledocholithiasis requires definitive treatment. 1, 2

Why Normal LFTs Don't Exclude the Need for Treatment

• Normal liver function tests do not exclude the diagnosis of choledocholithiasis when clinical suspicion remains high, and more importantly, they do not predict which patients will remain asymptomatic. 2
• Delaying definitive stone extraction in CBD stone patients—even asymptomatic ones—increases the risk of complications including cholangitis, pancreatitis, and hepatic dysfunction. 1
• The natural history shows that leaving CBD stones in place results in unfavorable outcomes, making observation an inappropriate strategy. 2

Treatment Options (Equally Valid)

Option 1: ERCP with Stone Extraction

• ERCP with stone extraction is the primary therapeutic approach and requires propofol sedation or general anesthesia for optimal success rates. 1
• Administer rectal NSAIDs (100 mg indomethacin or diclofenac) at the time of ERCP to reduce post-ERCP pancreatitis risk. 1, 2
• Check CBC and INR/PT before performing biliary sphincterotomy. 1

Option 2: Laparoscopic Bile Duct Exploration

• Laparoscopic bile duct exploration (LBDE) during cholecystectomy is equally valid, with no difference in efficacy, mortality, or morbidity compared to ERCP. 1, 3
• LBDE is associated with shorter hospital stays compared to ERCP. 1, 3

Critical Pitfall to Avoid

If the gallbladder remains in situ after endoscopic clearance of bile duct stones, the risk of recurrent biliary events including cholangitis markedly increases; therefore, completion cholecystectomy must be performed. 3, 2 This is a common error that leads to preventable morbidity.

What NOT to Do

• Medical dissolution therapy with ursodiol is contraindicated in patients with common bile duct obstruction, which is the defining feature of choledocholithiasis. 1
• Expectant management is only appropriate for asymptomatic gallbladder stones, not common bile duct stones. 3
• Watchful waiting for CBD stones increases complication risk and should not be pursued. 1

Timing Considerations

While your patient is currently asymptomatic, early definitive treatment within 2 weeks reduces the risk of recurrent biliary events; postponing intervention beyond 2–4 weeks significantly increases recurrence of pancreatitis and cholangitis. 2 The asymptomatic window represents an optimal opportunity for elective intervention before emergency complications develop.